BSE - Delayed Quote INR
Gennex Laboratories Limited (GENNEX.BO)
13.24
-0.58
(-4.20%)
At close: April 25 at 3:45:43 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
-466,864
236,762
119,081.50
-14,371.07
Investing Cash Flow
--
189,134
-383,286
-24,657.51
-249.59
Financing Cash Flow
--
736,838
210,331
-18,311.22
16,186
End Cash Position
--
609,750
150,642
86,835.22
10,691.48
Capital Expenditure
--
--
-397,858
-15,942.14
-787.75
Issuance of Capital Stock
--
798,315
304,391
--
--
Issuance of Debt
--
--
10,179
27,618.07
--
Repayment of Debt
--
-30,717
-90,701.40
-37,000
-154.90
Free Cash Flow
--
-466,864
-161,096
103,139.36
-15,158.82
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade